Drug
- All
- News
- Videos
- Photos
- Web Stories
-
1,200 Kg Adulterated Paneer, 900 Kg Contaminated Khoya Busted In Pre-Holi Food Safety Check
Food safety officials seized and disposed of over two tonnes (more than 2000 kg) of unsafe paneer, khoya, milk, spices, and other edible items in Uttar Pradesh.
-
1,800 Litres Of Hash Oil Worth Rs 200 Crores, 2,000 Kg Ganja Seized In Odisha
In one of the biggest anti-drug operations in southern Odisha, Koraput Police have seized more than 1,800 litres of hashish oil worth nearly Rs 200 crore and over two tonnes of ganja in separate raids across the district.
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
NEET Exam Wasn't The Reason Lucknow Man Killed, Chopped Up His Father
In an act of revenge, Akshat went to his father's room around 4 am, took the rifle, and shot him in his sleep.
-
Unmade Beds, Insomnia Medicines: Inside El Mencho's Final Hiding Place
Mexican drug cartel leader Nemesio Oseguera Cervantes, better known as 'El Mencho', spent his final days at a two-story villa in the exclusive, gated Tapalpa Country Club with one of his lovers.
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Alcohol Disrupts Brain Communication Even At Legal Driving Limit, Study Finds
A new brain imaging study of 107 adults has found that even moderate alcohol consumption reduces whole brain communication and increases localised activity.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
1,200 Kg Adulterated Paneer, 900 Kg Contaminated Khoya Busted In Pre-Holi Food Safety Check
Food safety officials seized and disposed of over two tonnes (more than 2000 kg) of unsafe paneer, khoya, milk, spices, and other edible items in Uttar Pradesh.
-
1,800 Litres Of Hash Oil Worth Rs 200 Crores, 2,000 Kg Ganja Seized In Odisha
In one of the biggest anti-drug operations in southern Odisha, Koraput Police have seized more than 1,800 litres of hashish oil worth nearly Rs 200 crore and over two tonnes of ganja in separate raids across the district.
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
NEET Exam Wasn't The Reason Lucknow Man Killed, Chopped Up His Father
In an act of revenge, Akshat went to his father's room around 4 am, took the rifle, and shot him in his sleep.
-
Unmade Beds, Insomnia Medicines: Inside El Mencho's Final Hiding Place
Mexican drug cartel leader Nemesio Oseguera Cervantes, better known as 'El Mencho', spent his final days at a two-story villa in the exclusive, gated Tapalpa Country Club with one of his lovers.
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Alcohol Disrupts Brain Communication Even At Legal Driving Limit, Study Finds
A new brain imaging study of 107 adults has found that even moderate alcohol consumption reduces whole brain communication and increases localised activity.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
